October 21, 2025
Holmes Chapel, UK, 21 October 2025 – Bespak, a specialist inhalation CDMO, has become a signatory of the United Nations Global Compact (UNGC), the largest global voluntary sustainability and social responsibility initiative.
With this development, Bespak now officially joins the collaborative UGNC network of over 20,000 companies and 3,800 non-business entities working to enact meaningful change.
Bespak has committed to adopting the UNGC’s ten principles in the core areas of sustainable development - human rights, labour, environment and anti-corruption. The pledge aligns with Bespak’s wider Environmental, Social, and Governance (ESG) strategy, which seeks to embed sustainability across its business and to support the global inhalation industry in reducing carbon footprint.
This announcement follows the recent approval from the Science Based Targets initiative (SBTi) of Bespak’s net-zero and near-term targets, which aim to reduce company-wide greenhouse gas emissions.
Benedicta Bakpa, Head of ESG at Bespak, said: “Being a UNGC signatory is a powerful opportunity to enact meaningful change both locally and on a global scale. As we drive growth, we will continue to consciously implement the ESG initiatives fundamental to our business.”
Chris Hirst, Bespak CEO, commented: “Since spinning out from Recipharm in 2024, we have embraced the United Nations Sustainable Development Goals, focusing on innovation, environmental responsibility, and efficient production. Joining the UNGC further reinforces Bespak’s strong commitment to championing a more sustainable inhalation industry and a greener tomorrow.”
For further information and interview opportunities with Bespak, please contact:
Notch Communications
About Bespak
Bespak is a specialist global contract development and manufacturing organisation (CDMO) solely focused on the inhaled and nasal drug delivery industry. It develops and manufactures inhaled and nasal drug products, drug delivery devices and components for the global pharmaceutical market. Headquartered in Holmes Chapel, UK, Bespak provides a specialist, fully integrated service to support customers from early-stage feasibility, analytical and formulation, product development and clinical supply, through to full-scale cGMP batch production.
With a long history in the development and commercial supply of pressurised Metered Dose Inhalers (pMDIs), Bespak supplies a major proportion of the world’s pMDI dosing valves and actuators. Built on established expertise but ready for the future, Bespak is a long-term innovation partner committed to driving sustainability in the industry. The company has both established capacity and ongoing expansions to enable the manufacture of pMDIs with low Global Warming Potential (GWP) propellants, making it well positioned to lead the green pMDI transition.
More information: www.bespak.com
